{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:50:43Z","timestamp":1769280643994,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,7,30]],"date-time":"2011-07-30T00:00:00Z","timestamp":1311984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00296-011-2036-2","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T11:40:19Z","timestamp":1311939619000},"page":"3281-3284","source":"Crossref","is-referenced-by-count":5,"title":["Rituximab treatment for Sjogren syndrome-associated non-Hodgkin\u2019s lymphoma: case series"],"prefix":"10.1007","volume":"32","author":[{"given":"M.","family":"Covelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lanciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Grattagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Angelelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,30]]},"reference":[{"key":"2036_CR1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2006","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2006) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"2036_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1568-9972(03)00102-2","volume":"3","author":"Y Masaki","year":"2004","unstructured":"Masaki Y, Sugai S (2004) Lymphoproliferative disorders in Sjogren\u2019s syndrome. Autoimmun Rev 3:175\u2013182","journal-title":"Autoimmun Rev"},{"key":"2036_CR3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0889-857X(21)00313-6","volume":"18","author":"N Talal","year":"1992","unstructured":"Talal N (1992) Sjogren\u2019s syndrome: historical overview and clinical spectrum of disease. Rheum Dis Clin North Am 18:507\u2013515","journal-title":"Rheum Dis Clin North Am"},{"key":"2036_CR4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999) Malignant lymphoma in primary Sjogren\u2019s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren\u2019s Syndrome. Arthritis Rheum 42:1765\u20131772","journal-title":"Arthritis Rheum"},{"key":"2036_CR5","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825\u20132833","journal-title":"J Clin Oncol"},{"key":"2036_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2169\/internalmedicine.41.124","volume":"41","author":"O Sakamoto","year":"2002","unstructured":"Sakamoto O, Saita N, Ando M, Kohrogi H, Suga M, Ando M (2002) Two cases of Sjogren\u2019s syndrome with multiple bullae. Intern Med 41:124\u2013128","journal-title":"Intern Med"},{"key":"2036_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00408-007-9002-5","volume":"185","author":"H Tokuyasu","year":"2007","unstructured":"Tokuyasu H, Watanabe E, Okazaki R, Kawasaki Y, Kikuchi R, Isowa N (2007) Sjogren\u2019s syndrome with multiple bullae caused by lymphocytic interstitial pneumonia. Lung 185:187\u2013188","journal-title":"Lung"},{"key":"2036_CR8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT (2006) Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796\u2013803","journal-title":"Ann Rheum Dis"},{"key":"2036_CR9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jcp.49.7.595","volume":"49","author":"LC Di","year":"1996","unstructured":"Di LC, Mariuzzi L, De GA, Beltrami CA (1996) B cell lymphoma of the thymus and salivary gland. J Clin Pathol 49:595\u2013597","journal-title":"J Clin Pathol"},{"key":"2036_CR10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000478-199004000-00005","volume":"14","author":"PG Isaacson","year":"1990","unstructured":"Isaacson PG, Chan JK, Tang C, Addis BJ (1990) Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitis. Am J Surg Pathol 14:342\u2013351","journal-title":"Am J Surg Pathol"},{"key":"2036_CR11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0046-8177(98)90211-8","volume":"29","author":"S Yamasaki","year":"1998","unstructured":"Yamasaki S, Matsushita H, Tanimura S, Nakatani T, Hara S, Endo Y, Hara M (1998) B-cell lymphoma of mucosa-associated lymphoid tissue of the thymus: a report of two cases with a background of Sjogren\u2019s syndrome and monoclonal gammopathy. Hum Pathol 29:1021\u20131024","journal-title":"Hum Pathol"},{"key":"2036_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.1780400217","volume":"40","author":"S Vita De","year":"1997","unstructured":"De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolceti R et al (1997) Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren\u2019s syndrome. Arthritis Rheum 40:318\u2013331","journal-title":"Arthritis Rheum"},{"key":"2036_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome. Rheumatology (Oxford) 44:89\u201394","journal-title":"Rheumatology (Oxford)"},{"key":"2036_CR14","doi-asserted-by":"crossref","unstructured":"Quartuccio L, Fabris M, Salvin S, Maset M, De Marchi G, De Vita S (2009) Controversies on rituximab therapy in sjogren syndrome-associated lymphoproliferation. Int J Rheumatol 2009:424935","DOI":"10.1155\/2009\/424935"},{"key":"2036_CR15","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","volume":"52","author":"J Pijpe","year":"2005","unstructured":"Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ et al (2005) Rituximab treatment in patients with primary Sjogren\u2019s syndrome: an open-label phase II study. Arthritis Rheum 52:2740\u20132750","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2036-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2036-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2036-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T04:10:13Z","timestamp":1638159013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2036-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,30]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2036-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,30]]}}}